Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fractio...
Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Heart failure (HF) with reduced ejection fraction (HFrEF) is a risk factor for drug-induced QT interval prolongation. It is unknown if HF with preserved ejection fraction (HFpEF) is also associated with an increased risk. Dofetilide and sotalol are potent QT interval-prolonging agents that are frequently used in patients with HFpEF, in whom atrial...
Alternative Titles
Full title
Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_3094725783
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3094725783
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0308999
